Février 2004

Dealing with the mandates of the Sarbanes-Oxley Act, even under a "relaxed" implementation schedule, has proven something of scramble for public companies. Many have found that the sheer volume of work has necessitated a process that favors speed over deliberation.

This haste is an unfortunate side effect of the strong medicine prescribed by Congress to improve corporate governance and restore investore confidence, something important has been left behind: context and perspective.

Anglais uniquement